학술논문
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
Document Type
Article
Author
Source
In Blood 1 September 2003 102(5):1578-1582
Subject
Language
ISSN
0006-4971